Guangzhou Wondfo Biotech Co.,Ltd (SHE:300482)

SHE:300482 Revenue

Guangzhou Wondfo Biotech Co.,Ltd had revenue of 456.76M CNY in the quarter ending June 30, 2026, with 2.56% growth. This brings the company's total for the last twelve months to 1.88B, down -31.28% year-over-year. In the year 2025, Guangzhou Wondfo Biotech Co.,Ltd had annual revenue of 2.09B, down -31.91%. That makes Guangzhou Wondfo Biotech Co.,Ltd the 14,941st largest company in the world by revenue and 2,678th in China.

• Revenue (ttm): 1.88B
• Revenue Growth: -31.28%
• P/S Ratio: 3.92
• Revenue / Employee: 769.42K
• Employees: 2,443
• Market Cap: 7.38B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• In Vitro Diagnostic Product 2.02B 96.9%
• Others 64.08M 3.1%

By Geography

Chart

• China 1.05B 50.4%
• Outside China 1.04B 49.6%

Fiscal year ended Dec 31, 2025 See the full SHE:300482 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.09B	-977.98M	-31.91%
Dec 31, 2024	3.06B	299.90M	10.85%
Dec 31, 2023	2.76B	-2.92B	-51.33%
Jan 1, 2023	5.68B	2.32B	69.01%
Dec 31, 2021	3.36B	550.20M	19.57%

Data Source: S&P Global Market Intelligence Last updated: Aug 23, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 24, 2026

Data Sources Report a data error